9 METERS BIOPHARMA, INC.
DelistedCIK 1551986fmd_0T321BR2NF8Z83H9N70Z3WR0B3Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2015 to Mar 31, 2023, 32 periods
Latest annual · FY2017
Millions- Gross profit
- (0)
- Operating income
- (42)
- Net income
- (44)
- Free cash flow
- (37)
Latest quarter · Q1 FY2023
Millions- Operating income
- (13)
- Net income
- (14)
- Free cash flow
- (10)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2017 to FY2022
- n/m
9 METERS BIOPHARMA, INC. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Operating income | -$42 million | -$36.8 million | 10-K 2023-03-28 · proof | |
| Net income | -$43.8 million | -$36.8 million | 10-K 2023-03-28 · proof | |
| Cash from operating activities | -$37.2 million | -$29.5 million | 10-K 2023-03-28 · proof | |
| Free cash flow | -$37.2 million | -$29.5 million | 10-K 2023-03-28 · proof | |
| Total assets | $33.1 million | $50.2 million | -33.9% | 10-K 2023-03-28 · proof |
| Total liabilities | $30.7 million | $8.6 million | +258.8% | 10-K 2023-03-28 · proof |
| Cash and cash equivalents | $12.6 million | $47 million | -73.1% | 10-K 2023-03-28 · proof |
- What was 9 METERS BIOPHARMA, INC.'s operating income in fiscal 2022?
- 9 METERS BIOPHARMA, INC. reported operating income of -$42 million for fiscal 2022 (the year ended Dec 31, 2022), against -$36.8 million the year before. Source: the 10-K filed with the SEC on Mar 28, 2023. SEC
- What was 9 METERS BIOPHARMA, INC.'s net income in fiscal 2022?
- 9 METERS BIOPHARMA, INC. reported net income of -$43.8 million for fiscal 2022 (the year ended Dec 31, 2022), against -$36.8 million the year before. Source: the 10-K filed with the SEC on Mar 28, 2023. SEC
- What was 9 METERS BIOPHARMA, INC.'s cash from operating activities in fiscal 2022?
- 9 METERS BIOPHARMA, INC. reported cash from operating activities of -$37.2 million for fiscal 2022 (the year ended Dec 31, 2022), against -$29.5 million the year before. Source: the 10-K filed with the SEC on Mar 28, 2023. SEC
- What was 9 METERS BIOPHARMA, INC.'s free cash flow in fiscal 2022?
- 9 METERS BIOPHARMA, INC. reported free cash flow of -$37.2 million for fiscal 2022 (the year ended Dec 31, 2022), against -$29.5 million the year before. Source: the 10-K filed with the SEC on Mar 28, 2023. SEC
- What are 9 METERS BIOPHARMA, INC.'s total assets?
- As of Dec 31, 2022, 9 METERS BIOPHARMA, INC. reported total assets of $33.1 million, against $50.2 million a year earlier (-33.9%). Source: the 10-K filed with the SEC on Mar 28, 2023. SEC
- What are 9 METERS BIOPHARMA, INC.'s total liabilities?
- As of Dec 31, 2022, 9 METERS BIOPHARMA, INC. reported total liabilities of $30.7 million, against $8.6 million a year earlier (+258.8%). Source: the 10-K filed with the SEC on Mar 28, 2023. SEC
- What are 9 METERS BIOPHARMA, INC.'s cash and cash equivalents?
- As of Dec 31, 2022, 9 METERS BIOPHARMA, INC. reported cash and cash equivalents of $12.6 million, against $47 million a year earlier (-73.1%). Source: the 10-K filed with the SEC on Mar 28, 2023. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1551986&period_type=annual&limit=5"Information only, not investment advice.